{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:36:25Z","timestamp":1774316185830,"version":"3.50.1"},"reference-count":34,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and Objectives<\/jats:title><jats:p>Blood donor opinions and behaviours regarding marijuana use are not well known nor is the potential impact to the blood supply. We sought to assess opinions and frequency of marijuana use in proximity to blood donation via a survey of blood donors at a hospital\u2010based blood collection site in a state where recreational marijuana use has been legal since 2012.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>Blood donors at least 18\u2009years of age who donated between 2014 and 2019 were surveyed electronically, with all responses kept anonymous to encourage engagement and accurate reporting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall response rate was 8.03% (12,186 surveys sent with 979 responses). Of responding donors, 23.5% indicated that they felt that consuming various forms of marijuana was acceptable prior to blood donation. Marijuana use &lt;72\u2009h prior to blood donation was reported in all demographic groups surveyed except age 18\u201324\u2009years. Of donors who reported daily marijuana use, 47.4% indicated &gt;20 donations and 52.6% indicated apheresis platelet donation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Nearly one quarter of responding blood donors feel that marijuana use is acceptable prior to blood donation, and nearly every demographic group surveyed indicated use of marijuana &lt;72\u2009h prior to donation. These results suggest the need for additional research to determine if marijuana\u2010related metabolites in collected blood products negatively impact recipients, particularly vulnerable populations such as children and pregnant women. These results may inform whether changes in donor screening or testing for marijuana use are warranted.<\/jats:p><\/jats:sec>","DOI":"10.1111\/vox.13183","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T09:05:27Z","timestamp":1626944727000},"page":"177-184","source":"Crossref","is-referenced-by-count":3,"title":["Perceptions on acceptability and reported consumption of marijuana by blood donors prior to donation in the recreational use state of Colorado, <scp>USA<\/scp>"],"prefix":"10.1111","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7192-5057","authenticated-orcid":false,"given":"Kyle","family":"Annen","sequence":"first","affiliation":[{"name":"Department of Pathology University of Colorado School of Medicine  Aurora Colorado USA"},{"name":"Department of Pathology and Laboratory Medicine Children's Hospital Colorado  Aurora Colorado USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melkon G.","family":"DomBourian","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Colorado School of Medicine  Aurora Colorado USA"},{"name":"Department of Pathology and Laboratory Medicine Children's Hospital Colorado  Aurora Colorado USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"Colorado Joint Select Committee Legislation:Amendment 64 Implementation.https:\/\/www.colorado.gov\/pacific\/sites\/default\/files\/13%20Amendment%2064%20LEGIS.pdf(2013). Accessed 15 Mar 2021."},{"key":"e_1_2_7_3_1","unstructured":"Washington state initiative 502.https:\/\/www.sos.wa.gov\/_assets\/elections\/initiatives\/i502.pdf(2012). Accessed 15 Mar 2021."},{"key":"e_1_2_7_4_1","unstructured":"Hansen C. Alas H.States where marijuana is legal: A guide to marijuana legalization. U.S. news and world report: Best states.2020.https:\/\/www.usnews.com\/news\/best-states\/articles\/where-is-marijuana-legal-a-guide-to-marijuana-legalization. Accessed 15 Mar 2021."},{"key":"e_1_2_7_5_1","unstructured":"Colorado House of Representatives:116th congress. HR\u20103884.https:\/\/www.congress.gov\/116\/bills\/hr3884\/BILLS-116hr3884rh.pdf(2019). Accessed 24 Feb 2021."},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13282"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30208-5"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2017.07.008"},{"key":"e_1_2_7_9_1","unstructured":"Federal Drug Administration:Guidance for industry: Implementation of acceptable full\u2010length and abbreviated donor history questionnaires and accompanying materials for use in screening donors of blood and blood components.https:\/\/www.f.gov\/regulatory-information\/search-fda-guidance-documents\/implementation-acceptable-full-length-and-abbreviated-donor-history-questionnaires-and-accompanying(2020). Accessed 13 Jan 2021."},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqy176"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.06.010"},{"key":"e_1_2_7_12_1","unstructured":"FDA:Question and answer summary on cannabis use.https:\/\/www.fda.gov\/news-events\/public-health-focus\/fda-regulation-cannabis-and-cannabis-derived-products-questions-and-answers(2019). Accessed 24 Feb 2021."},{"key":"e_1_2_7_13_1","first-page":"L 91\/25\u201339","article-title":"Commission directive 2004\/33\/EC of 22 March 2004: implementing certain technical requirements for blood and blood components","year":"2004","journal-title":"Off J Eur Union"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2682"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2003.00264.x"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1974.tb09207.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.200790152"},{"key":"e_1_2_7_18_1","first-page":"110","article-title":"Maternal\u2010fetal transfer of abused substances: pharmacokinetic and pharmacodynamic data","volume":"60","author":"Lee CC","year":"1985","journal-title":"NIDA Res Monogr"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500375"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2016.04.021"},{"key":"e_1_2_7_21_1","first-page":"64","volume-title":"AABB standards for blood banks and transfusion services","author":"Transfusion Services Standards Committee","year":"2020"},{"key":"e_1_2_7_22_1","unstructured":"Colorado 73rdGeneral Assembly:Employee protection lawful off\u2010duty activities. HB20\u2010189.https:\/\/leg.colorado.gov\/bills\/hb20-1089. Accessed 25 Feb 2021."},{"key":"e_1_2_7_23_1","unstructured":"StamL.Employment and human rights law in Canada.https:\/\/www.canadaemploymenthumanrightslaw.com\/2018\/10\/legal-pot-drug-testing-off-duty-substance-use\/. Accessed 15 Mar 2021."},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40060637.x"},{"key":"e_1_2_7_25_1","first-page":"442","article-title":"Legal issues for blood banks","volume":"118","author":"Bierig JR","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-2712(18)30489-X"},{"key":"e_1_2_7_27_1","first-page":"1","article-title":"Blood bank trade group held liable for HIV\u2010tainted transfusion","volume":"11","year":"1996","journal-title":"AIDS Policy Law"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1089\/can.2016.0010"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/20.6.441"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.02.005"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2018.08.036"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009986"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1159\/000203355"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12668"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2019-0600"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vox.13183","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/vox.13183","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vox.13183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T15:00:00Z","timestamp":1692630000000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vox.13183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1111\/vox.13183"],"URL":"https:\/\/doi.org\/10.1111\/vox.13183","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]}}}